Sacral nerve neurostimulation-neuromodulation in the treatment of lower urinary tract dysfunction.<br /> Basic principles-indications-clinical application-results <br /> <br />
Journal Title: Αρχεία Ελληνικής Ιατρικής - Year 2007, Vol 24, Issue 3
Abstract
During the last fifteen years, sacral nerve neuromodulation-neurostimulation has begun to be developed as a therapeutic tool for the treatment of refractory chronic lower urinary tract dysfunction. This is a comprehensive review of the current state of the art of this surgical innovation in terms of basic principles, indications, clinical application, complications and results. The mode of action of neuromodulation is still not fully understood, but it is hypothesized that the electrical current modulates reflex pathways involved in the filling and evacuation phases of the micturition cycle, rebalancing micturition control. The main indication for intervention is chronic voiding dysfunction, refractory to conventional treatments, causing urgency-frequency syndrome, urge incontinence and idiopathic (non-neurogenic) voiding difficulty. Less common indications are multiple sclerosis, suprasacral spinal cord injuries, stroke, and Parkinson's disease. Its clinical application consists principally of three stages: Percutaneous location of the sacral spinal nerve with a needle electrode, percutaneous test stimulation with wire electrodes to assess the therapeutic potential in the individual patient over a period of 4 to 14 days, and permanent implantation of the neurostimulation device. Complications are usually minimal (rate 22-43%) and can be classified into surgery-related morbidity, neurophysiological alterations and hardware problems. The mean total clinical success rate has been estimated to be 88%, 80% and 71% in cases of urgency-frequency, urge incontinence and idiopathic urinary retention, respectively. On the basis of these results, it appears that sacral nerve neuromodulation represents an effective alternative treatment modality in patients with various forms of chronic lower urinary tract dysfunction refractory to conventional treatment, successfully bridging the gap between conservative treatment options and highly invasive surgical procedures.
Authors and Affiliations
E. SPYROPOULOS
Keywords
Related Articles
- EP ID EP139222
- DOI -
- Views 89
- Downloads 0
5q- syndrome [del(5q) MDS]
A 66-year-old lady presented to the outpatient clinic because of progressive normochromic macrocytic anemia of nine months duration, causing fatigue, weakness and malaise. She was treated, before her admission, with intr...
Inhibition of proprotein convertase subtilisin/kexin type 9 (PCSK9): A new approach in lipid lowering treatment
Cardiovascular disease is the single most common cause of death worldwide; hence its prevention constitutes a strategic target for the improvement of life expectancy and quality of life. Statins have been an essential el...
Mesenteric lymphatic malformations.
No abstract available
History of mastectomy
Incidents of breast cancer have been documented back to the early Egyptians. Hippocrates was the first who used the term of cancer "karkinos" or "karkinoma" of the nose, the uterus, the breasts and the neck. He believed...
Deontological problems in clinical research: The Informed Consent Document
Clinical research, that is to say research on human beings, has contributed considerably to the improvement of the health of society, but has also caused the appearance of a variety of problems in the wider sector of the...